{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:24:32Z","timestamp":1793949872865,"version":"4.8.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T00:00:00Z","timestamp":1538006400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572647 and 81372902"],"award-info":[{"award-number":["81572647 and 81372902"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402234"],"award-info":[{"award-number":["81402234"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"postdoctoral scientific research developmental fund","award":["(LBH-Q16157"],"award-info":[{"award-number":["(LBH-Q16157"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head Face Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13005-018-0177-1","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T08:14:49Z","timestamp":1538036089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effect of DACH1 on proliferation and invasion of laryngeal squamous cell carcinoma"],"prefix":"10.1186","volume":"14","author":[{"given":"Jiarui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxia","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linli","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,27]]},"reference":[{"key":"177_CR1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.otc.2008.01.016","volume":"41","author":"EA Chu","year":"2008","unstructured":"Chu EA, Kim YJ. Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngol Clin N Am. 2008;41:673\u201395. \n                    https:\/\/doi.org\/10.1016\/j.otc.2008.01.016\n                    \n                  .","journal-title":"Otolaryngol Clin N Am"},{"key":"177_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/bjc.2014.217","volume":"111","author":"L Ellis","year":"2014","unstructured":"Ellis L, Coleman MP, Rachet B. The impact of life tables adjusted for smoking on the socio-economic difference in net survival for laryngeal and lung cancer. Br J Cancer. 2014;111:195\u2013202. \n                    https:\/\/doi.org\/10.1038\/bjc.2014.217\n                    \n                  .","journal-title":"Br J Cancer"},{"key":"177_CR3","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/hed.23653","volume":"37","author":"KL Connor","year":"2015","unstructured":"Connor KL, Pattle S, Kerr GR, et al. Treatment, comorbidity and survival in stage III laryngeal cancer. Head Neck. 2015;37:698\u2013706. \n                    https:\/\/doi.org\/10.1002\/hed.23653\n                    \n                  .","journal-title":"Head Neck"},{"key":"177_CR4","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.18632\/oncotarget.3463","volume":"6","author":"N Han","year":"2015","unstructured":"Han N, Yuan X, Wu H, et al. DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling. Oncotarget. 2015;6:5877\u201388. \n                    https:\/\/doi.org\/10.18632\/oncotarget.3463\n                    \n                  .","journal-title":"Oncotarget"},{"key":"177_CR5","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/ijc.29560","volume":"138","author":"Y Liu","year":"2016","unstructured":"Liu Y, Han N, Zhou S, et al. The DACH\/EYA\/SIX gene network and its role in tumor initiation and progression. Int J Cancer. 2016;138:1067\u201375. \n                    https:\/\/doi.org\/10.1002\/ijc.29560\n                    \n                  .","journal-title":"Int J Cancer"},{"key":"177_CR6","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.bbrc.2015.03.032","volume":"460","author":"P Wang","year":"2015","unstructured":"Wang P. Suppression of DACH1 promotes migration and invasion of colorectal cancer via activating TGF-\u03b2-mediated epithelial-mesenchymal transition. Biochem Biophys Res Commun. 2015;460:314\u20139. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2015.03.032\n                    \n                  .","journal-title":"Biochem Biophys Res Commun"},{"key":"177_CR7","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1038\/oncsis.2015.3","volume":"4","author":"F Zhao","year":"2015","unstructured":"Zhao F, Wang M, Li S, et al. DACH1 inhibits SNAI1-mediated epithelial\u2013mesenchymal transition and represses breast carcinoma metastasis. Oncogenesis. 2015;4:e143. \n                    https:\/\/doi.org\/10.1038\/oncsis.2015.3\n                    \n                  .","journal-title":"Oncogenesis"},{"key":"177_CR8","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1007\/s13277-014-2913-x","volume":"36","author":"P Jaros\u0142aw","year":"2015","unstructured":"Jaros\u0142aw P, Joanna S, Magdalena KP, et al. The negative regulators of Wnt pathway\u2014DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival. Tumour Biol. 2015;36:2855\u201361. \n                    https:\/\/doi.org\/10.1007\/s13277-014-2913-x\n                    \n                  .","journal-title":"Tumour Biol"},{"key":"177_CR9","doi-asserted-by":"publisher","first-page":"6864","DOI":"10.1073\/pnas.1002746107","volume":"107","author":"J Zhou","year":"2010","unstructured":"Zhou J, Wang C, Wang Z, et al. Attenuation of Forkhead signaling by the retinal determination factor DACH1. Proc Natl Acad Sci U S A. 2010;107:6864\u20139. \n                    https:\/\/doi.org\/10.1073\/pnas.1002746107\n                    \n                  .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"177_CR10","doi-asserted-by":"publisher","first-page":"e95509","DOI":"10.1371\/journal.pone.0095509","volume":"9","author":"L Wu","year":"2014","unstructured":"Wu L, Herman JG, Brock MV, et al. Silencing DACH1 promotes esophageal Cancer growth by inhibiting TGF-\u03b2 signaling. PLoS One. 2014;9:e95509. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0095509\n                    \n                  .","journal-title":"PLoS One"},{"key":"177_CR11","doi-asserted-by":"publisher","first-page":"923","DOI":"10.18632\/oncotarget.1094","volume":"4","author":"K Chen","year":"2013","unstructured":"Chen K, Wu K, Gormley M, et al. Acetylation of the cell-fate factor dachshund determines p53 binding and signaling modules in breast Cancer. Oncotarget. 2013;4:923\u201335. \n                    https:\/\/doi.org\/10.18632\/oncotarget.1094\n                    \n                  .","journal-title":"Oncotarget"},{"issue":"1","key":"177_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/ijerph13010112","volume":"13","author":"Hui Huangfu","year":"2016","unstructured":"Hui HF, Pan H, Wang BQ, et al. Association between UGT1A1 polymorphism and risk of laryngeal squamous cell carcinoma. \n                    Int J Environ Res Public Health\n                    \n                  . 2016;13. \n                    https:\/\/doi.org\/10.3390\/ijerph13010112\n                    \n                  .","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"177_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3322\/caac.20121","volume":"61","author":"R Siegel","year":"2011","unstructured":"Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on pre-mature cancer deaths. CA-Cancer J Clin. 2011;61:212\u201336. \n                    https:\/\/doi.org\/10.3322\/caac.20121\n                    \n                  .","journal-title":"CA-Cancer J Clin"},{"key":"177_CR14","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1039\/c5mb00685f","volume":"12","author":"R Sun","year":"2016","unstructured":"Sun R, Qin C, Jiang B, et al. Down-regulation of MALAT1 inhibits cervical cancer cell invasion and metastasis by inhibition of epithelial-mesenchymal transition. Mol BioSyst. 2016;12:952\u201362. \n                    https:\/\/doi.org\/10.1039\/c5mb00685f\n                    \n                  .","journal-title":"Mol BioSyst"},{"key":"177_CR15","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1158\/0008-5472.CAN-13-2466","volume":"74","author":"K Wu","year":"2015","unstructured":"Wu K, Chen K, Wang C, et al. Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation. Cancer Res. 2015;74:829\u201339. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-2466\n                    \n                  .","journal-title":"Cancer Res"},{"key":"177_CR16","doi-asserted-by":"publisher","first-page":"9781","DOI":"10.1007\/s13277-016-4811-x","volume":"37","author":"J Zhu","year":"2016","unstructured":"Zhu J, Wu C, Li H, et al. DACH1 inhibits the proliferation and invasion of lung adenocarcinoma through the downregulation of peroxiredoxin 3. Tumour Biol. 2016;37:9781\u20138. \n                    https:\/\/doi.org\/10.1007\/s13277-016-4811-x\n                    \n                  .","journal-title":"Tumour Biol"},{"key":"177_CR17","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.4161\/cbt.8.16.8963","volume":"8","author":"FF Nan","year":"2009","unstructured":"Nan FF, L\u00fc QT, Zhou J, et al. Altered expression of DACH1 and cyclin D1 in endometrial cancer. Cancer Biol Ther. 2009;8:1534\u20139.","journal-title":"Cancer Biol Ther"},{"key":"177_CR18","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1002\/hep.26587","volume":"58","author":"HB Zhu","year":"2013","unstructured":"Zhu HB, Wu HM, Yan WJ, et al. Epigenetic silencing of DACH1 induces loss of transforming growth fact or \u03b21 antiproliferative response in human hepatocelluar carcinoma. Hepatology. 2013;58:2012\u201322. \n                    https:\/\/doi.org\/10.1002\/hep.26587\n                    \n                  .","journal-title":"Hepatology"},{"key":"177_CR19","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.4161\/epi.26781","volume":"8","author":"WJ Yan","year":"2013","unstructured":"Yan WJ, Wu KM, Herman JG, et al. Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer. Epigenetics. 2013;8:1373\u201383. \n                    https:\/\/doi.org\/10.4161\/epi.26781\n                    \n                  .","journal-title":"Epigenetics"},{"key":"177_CR20","doi-asserted-by":"publisher","first-page":"e84428","DOI":"10.1371\/journal.pone.0084428","volume":"9","author":"DG Powe","year":"2014","unstructured":"Powe DG, Dhondalay GKR, Lemetre C, et al. DACH1: its role as a classifier of long term good prognosis in luminal breast Cancer. PLoS One. 2014;9:e84428. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0084428\n                    \n                  .","journal-title":"PLoS One"},{"key":"177_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.bbrc.2012.08.048","volume":"426","author":"JW Lee","year":"2012","unstructured":"Lee JW, Kim HS, Hwang J, et al. Regulatiion of HOXA9 activity by predominant expression of DACH1 against C\/EBPa and GATA-1 in myeloid leukemia with MLL-AF9. Biochem Biophys Res Commun. 2012;426:299\u2013305. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2012.08.048\n                    \n                  .","journal-title":"Biochem Biophys Res Commun"},{"key":"177_CR22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/IGC.0b013e31824311e6","volume":"22","author":"F Liang","year":"2012","unstructured":"Liang F, L\u00fc Q, Sun S, et al. Increased expression of dachshund homolog 1 in ovarian cancer as a predictor for poor outcome. Int J Gynecol Cancer. 2012;22:386\u201393. \n                    https:\/\/doi.org\/10.1097\/IGC.0b013e31824311e6\n                    \n                  .","journal-title":"Int J Gynecol Cancer"},{"key":"177_CR23","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1111\/jcmm.12325","volume":"18","author":"WJ Yan","year":"2014","unstructured":"Yan WJ, Wu KM, Herman JG, et al. Epigenetic silencing of DACH1 induces the invasion and metastasis of gastric cancer by activating TGF-\u03b2 signalling. J Cell Mol Med. 2014;18:2499\u2013511. \n                    https:\/\/doi.org\/10.1111\/jcmm.12325\n                    \n                  .","journal-title":"J Cell Mol Med"},{"key":"177_CR24","doi-asserted-by":"publisher","first-page":"8621","DOI":"10.18632\/oncotarget.3281","volume":"6","author":"Y Liu","year":"2015","unstructured":"Liu Y, Zhou R, Yuan X, et al. DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt\/ \u03b2-catenin signaling. Oncotarget. 2015;6:8621\u201334. \n                    https:\/\/doi.org\/10.18632\/oncotarget.3281\n                    \n                  .","journal-title":"Oncotarget"},{"key":"177_CR25","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3892\/or.2013.2960","volume":"31","author":"J Zhang","year":"2014","unstructured":"Zhang J, Zhao CY, Zhang SH, et al. Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma. Oncol Rep. 2014;31:1157\u201364. \n                    https:\/\/doi.org\/10.3892\/or.2013.2960\n                    \n                  .","journal-title":"Oncol Rep"},{"key":"177_CR26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.7150\/jca.10822","volume":"6","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Yuan YH, Cui JC, et al. MiR-217 promotes tumor Proloferation in breast Cancer via targeting DACH1. J Cancer. 2015;6:184\u201391. \n                    https:\/\/doi.org\/10.7150\/jca.10822\n                    \n                  .","journal-title":"J Cancer"},{"key":"177_CR27","doi-asserted-by":"publisher","first-page":"6924","DOI":"10.1073\/pnas.0802085105","volume":"105","author":"KM Wu","year":"2008","unstructured":"Wu KM, Katiyar S, Li A, et al. Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8. PNAS. 2008;105:6924\u20139. \n                    https:\/\/doi.org\/10.1073\/pnas.0802085105\n                    \n                  .","journal-title":"PNAS"},{"key":"177_CR28","doi-asserted-by":"publisher","first-page":"40342","DOI":"10.1074\/jbc.M110.156141","volume":"285","author":"J Zhou","year":"2010","unstructured":"Zhou J, Liu Y, Zhang W, et al. Transcription elongation regulator 1 is a co-integrator of the cell fate determination factor dachshund homolog 1. J Biol Chem. 2010;285:40342\u201350. \n                    https:\/\/doi.org\/10.1074\/jbc.M110.156141\n                    \n                  .","journal-title":"J Biol Chem"},{"key":"177_CR29","doi-asserted-by":"publisher","first-page":"7116","DOI":"10.1128\/MCB.00268-06","volume":"26","author":"KM Wu","year":"2006","unstructured":"Wu KM, Li AP, Rao M, et al. DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth. Mol Cell Biol. 2006;26:7116\u201329. \n                    https:\/\/doi.org\/10.1128\/MCB.00268-06\n                    \n                  .","journal-title":"Mol Cell Biol"},{"key":"177_CR30","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1091\/mbc.E06-09-0793","volume":"18","author":"KM Wu","year":"2007","unstructured":"Wu KM, Liu MR, Li AP, et al. Cell fate determination factor DACH1 inhibits c-Jun\u2013induced contact-independent growth. Mol Biol Cell. 2007;18:755\u201367. \n                    https:\/\/doi.org\/10.1091\/mbc.E06-09-0793\n                    \n                  .","journal-title":"Mol Biol Cell"},{"key":"177_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-014-0073-5","volume":"7","author":"Q Chu","year":"2014","unstructured":"Chu Q, Han N, Yuan X, et al. DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells. J Hematol Oncol. 2014;7:73. \n                    https:\/\/doi.org\/10.1186\/s13045-014-0073-5\n                    \n                  .","journal-title":"J Hematol Oncol"},{"key":"177_CR32","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1074\/jbc.M110.148395","volume":"286","author":"K Wu","year":"2011","unstructured":"Wu K, Jiao X, Li Z, et al. Cell fate determination factor dachshund reprograms breast Cancer stem cell function. J Biol Chem. 2011;286:2132\u201342. \n                    https:\/\/doi.org\/10.1074\/jbc.M110.148395\n                    \n                  .","journal-title":"J Biol Chem"},{"key":"177_CR33","doi-asserted-by":"publisher","first-page":"5752","DOI":"10.1158\/0008-5472.CAN-08-3992","volume":"69","author":"VM Popov","year":"2009","unstructured":"Popov VM, Zhou J, Shirley LA, et al. The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling. Cancer Res. 2009;69:5752\u201360. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-3992\n                    \n                  .","journal-title":"Cancer Res"},{"key":"177_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.tem.2009.08.002","volume":"21","author":"VM Popov","year":"2010","unstructured":"Popov VM, Wu K, Zhou J, et al. The dachshund gene in development and hormone-responsive tumorigenesis. Trends Endocrinol Metab. 2010;21:41\u20139. \n                    https:\/\/doi.org\/10.1016\/j.tem.2009.08.002\n                    \n                  .","journal-title":"Trends Endocrinol Metab"},{"key":"177_CR35","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1158\/0008-5472.CAN-12-3191","volume":"73","author":"K Chen","year":"2013","unstructured":"Chen K, Wu K, Cai S, et al. Dachshund binds p53 to block the growth of lung adenocarcinoma cells. Cancer Res. 2013;73:3262\u201374. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-3191\n                    \n                  .","journal-title":"Cancer Res"},{"key":"177_CR36","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/onc.2009.360","volume":"29","author":"SJ Miller","year":"2010","unstructured":"Miller SJ, Lan ZD, Hardiman A, et al. Inhibition of eyes absent homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis. Oncogene. 2010;29:368\u201379. \n                    https:\/\/doi.org\/10.1038\/onc.2009.360\n                    \n                  .","journal-title":"Oncogene"},{"key":"177_CR37","doi-asserted-by":"publisher","first-page":"51673","DOI":"10.1074\/jbc.M310021200","volume":"278","author":"K Wu","year":"2003","unstructured":"Wu K, Yang Y, Wang C, et al. DACH1 inhibits transforming growth factor-\u03b2 signaling through binding Smad4. J Biol Chem. 2003;278:51673\u201384. \n                    https:\/\/doi.org\/10.1074\/jbc.M310021200\n                    \n                  .","journal-title":"J Biol Chem"},{"key":"177_CR38","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1158\/0008-5472.CAN-08-3821","volume":"69","author":"K Wu","year":"2009","unstructured":"Wu K, Katiyar S, Witkiewicz A, et al. The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth. Cancer Res. 2009;69:3347\u201355. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-3821\n                    \n                  .","journal-title":"Cancer Res"},{"key":"177_CR39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.oooo.2015.08.021","volume":"121","author":"L Zhang","year":"2016","unstructured":"Zhang L, Wang CQ, Liu F, et al. Effects of human dachshund homolog 1 on the proliferation, migration, and adhesion of squamous cell carcinoma of the tongue. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121:58\u201366. \n                    https:\/\/doi.org\/10.1016\/j.oooo.2015.08.021\n                    \n                  .","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"177_CR40","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1158\/0008-5472.CAN-14-0611","volume":"75","author":"K Chen","year":"2015","unstructured":"Chen K, Wu K, Jiao X, et al. The endogenous cell-fate factor dachshund restrains prostate epithelial cell migration via repression of cytokine secretion via a CXCL signaling module. Cancer Res. 2015;75:1992\u20132004. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0611\n                    \n                  .","journal-title":"Cancer Res"}],"container-title":["Head & Face Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13005-018-0177-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13005-018-0177-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13005-018-0177-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T19:12:07Z","timestamp":1569525127000},"score":1,"resource":{"primary":{"URL":"https:\/\/head-face-med.biomedcentral.com\/articles\/10.1186\/s13005-018-0177-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,27]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["177"],"URL":"https:\/\/doi.org\/10.1186\/s13005-018-0177-1","relation":{},"ISSN":["1746-160X"],"issn-type":[{"value":"1746-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,27]]},"assertion":[{"value":"11 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Linli Tian is a professor of ENT at the Harbin Medical University, who serves at the second affiliated hospital from 2003 to now. She specializes in working with the laryngopharyngeal diseases.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional guidelines on human experimentation (the ethic committee of the Second Affiliated Hospital, Harbin Medical University). The number is KY2017\u2013009. All of patients are agree to publish their informations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients have consent to publish. The authors all consent for publition.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"20"}}